Skip to main content

Animations

MJFF Publications

4931 - 4940 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2023
  • 2022
  • 2018
  • 2016
  • 2020
  • 2015
  • 2019
  • 2024
  • Summary Details
    OPEN
    Title: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172957
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Aging, Parkinson’s Disease, and Models: What Are the Challenges?
    Journal Name: Aging Biology
    Publisher: Aging Biology LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.59368/agingbio.20230010
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.009
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0166053
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28360
    Citation Count: 78
  • Summary Details
    OPEN
    Title: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddv453
    Citation Count: 78
  • Summary Details
    RESTRICTED
    Title: Hypertension and progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27158
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.